Prospects for a return to full normalcy in the entire country are far more certain in one to one and a half years. The process of bringing a vaccine against Covid-19 to the general population is proceeding at breakneck speed. Six vaccines have already entered human trials. The first of them, developed by Modern Inc and backed by the US National Institutes of Health, began Phase 1 trials almost two months ago on March 3.
The latest one, developed at Jenner Institute of the University of Oxford, began human trial on April 23. Ambitiously, the team piloting this project says that it will be ready with one million doses of the vaccine as early as September. Accounting for approval process and mass production, we can reasonably expect to vaccinate a large proportion of the population in one and a half years, even sooner.